Related Experiment Video
Updated: Jul 3, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Problems associated with long-term treatment with selective serotonin reuptake inhibitors
1NeuroBiz Consulting & Communication, Castres, France. chantal.moret@neurobiz.com
Selective serotonin reuptake inhibitors (SSRIs) are common depression treatments but can cause serious, long-term side effects. These adverse events impact quality of life and may mimic depression symptoms, affecting patient adherence.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for depression and psychiatric disorders.
- While generally well-tolerated, SSRIs can cause adverse events, particularly with long-term use.
Purpose of the Study:
- To provide an overview of common adverse events associated with non-acute, long-term SSRI treatment.
- To highlight serious SSRI side effects that may be mistaken for depression symptoms.
Main Methods:
- Literature review of adverse events reported with SSRI use.
- Analysis of side effects occurring beyond the initial treatment phase.
Main Results:
- Short-term SSRI side effects are typically transient.
- Long-term SSRI use can lead to serious adverse events, some life-threatening.
- These events can negatively affect patient quality of life and treatment compliance.
Conclusions:
- Long-term SSRI treatment carries risks of serious adverse events.
- Recognizing these events is crucial for patient management and adherence.
- Adverse events are a significant factor in treatment non-compliance and depression relapse.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Desensitization and Tachyphylaxis
Several...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting Neurotransmitter Release or Uptake
